NYSE:EW

Edwards Lifesciences Stock News

etoro logo Buy EW
*Your capital is at risk
$86.00
-1.66 (-1.89%)
At Close: Jun 03, 2026
Although the revenue and EPS for Edwards Lifesciences (EW) give a sense of how its business performed in the quarter ended December 2022, it might be worth considering how some key metrics compare wit
Edwards Lifesciences Corp (NYSE:EW ) Q4 2022 Earnings Conference Call January 31, 2023 5:00 PM ET Company Participants Mark Wilterding - VP, IR Michael Mussallem - Chairman & CEO Scott Ullem - Corpora
Edwards Lifesciences (EW) delivered earnings and revenue surprises of 4.92% and 1.28%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Edwards Lifesciences narrowly beat fourth-quarter forecasts, and EW stock rose in after-hours action Tuesday. The post Edwards Lifesciences Stock Jumps After Beating Fourth-Quarter Views appeared firs
Edwards Lifesciences (EW) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
IRVINE, Calif. , Jan. 24, 2023 /PRNewswire/ -- Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended December 31, 2022 after the market closes on Tuesday, Janua
HOLX vs. EW: Which Stock Is the Better Value Option?

Ranking The Diversified Healthcare Giants

10:53pm, Sunday, 22'nd Jan 2023
The Top Six Healthcare Products and Service companies are some of the most popular investments in the market. However, they offer varying financial profiles.
Edwards Lifesciences (EW) continues to witness strong momentum of the RESILIA portfolio globally.
Edwards Lifesciences is a high quality business by any and all measures. Edwards has an excellent financial profile, a history of organic growth as opposed to growth via M&A, and a history of returnin
Strong adoption of the MITRIS RESILIA valve and increased demand for the HemoSphere monitoring platform will likely drive Edwards Lifesciences' (EW) Q4 revenues.
HOLX vs. EW: Which Stock Is the Better Value Option?
IRVINE, Calif. , Jan. 5, 2023 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW) today announced it will participate in the J.P.
Down 40%+ this year, EW is now trading at levels not seen in years. I believe the sell-off is unjust, and investors over the next few months will benefit immensely.
In the worst year for stocks since the Great Recession, several big names are headed for their worst year on record with just one trading day left in 2022.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE